Jyong Biotech Ltd. (MENS)Healthcare | Biotechnology | New Taipei City, Taiwan | NasdaqGM
2.27 USD
-0.04
(-1.695%) ⇩
(April 21, 2026, 11:08 a.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 1:47 a.m. EDT
Avoid. Jyong Biotech is a value trap with a net-cash position, negative book value, and no revenue trajectory visible in the data. The recent 49% plunge and de-listing risk warnings suggest a deteriorating fundamental reality. Despite a slight positive forecasted direction from a statistical model, the lack of liquidity, next-to-zero options flow, and toxic balance sheet make this a non-quality asset in any timeframe. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.328682 |
| AutoETS | 0.329973 |
| MSTL | 0.468034 |
| AutoTheta | 1.096765 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.34 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.289 |
| Excess Kurtosis | -0.50 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 172,582,800 |
| Website | https://jyongbio.com |
As of April 19, 2026, 1:47 a.m. EDT: Options activity indicates extreme distance disparity (DVOL) and inverted implied volatility (IV > 700% for puts compared to 3% for calls). This suggests a mixture of aggressive selling pressure and potential 'put buying' at strikes near the current price, likely hedging by short sellers or following the recent 49% price drop. However, volume and open interest are exceptionally low (near zero on most strikes), indicating a lack of genuine institutional positioning or meaningful investor sentiment alignment.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.77151334 |
| Address1 | No. 95, Xintai 5th Road |
| Address2 | 23F-3 Section 1 Xizhi District |
| All Time High | 67.0 |
| All Time Low | 1.43 |
| Ask | 2.95 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 125,020 |
| Average Daily Volume3 Month | 288,367 |
| Average Volume | 288,367 |
| Average Volume10Days | 125,020 |
| Bid | 1.72 |
| Bid Size | 2 |
| Book Value | -0.313 |
| City | New Taipei City |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.27 |
| Current Ratio | 0.623 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.4299 |
| Day Low | 2.27 |
| Display Name | Jyong Biotech |
| Ebitda | -1,803,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -102.023 |
| Enterprise Value | 183,947,984 |
| Eps Trailing Twelve Months | -0.04 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.1604 |
| Fifty Day Average Change | 0.10960007 |
| Fifty Day Average Change Percent | 0.05073138 |
| Fifty Two Week Change Percent | -77.15134 |
| Fifty Two Week High | 67.0 |
| Fifty Two Week High Change | -64.73 |
| Fifty Two Week High Change Percent | -0.96611947 |
| Fifty Two Week Low | 1.43 |
| Fifty Two Week Low Change | 0.84000003 |
| Fifty Two Week Low Change Percent | 0.58741266 |
| Fifty Two Week Range | 1.43 - 67.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,750,167,000,000 |
| Float Shares | 27,631,135 |
| Full Exchange Name | NasdaqGM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.62205005 |
| Held Percent Institutions | 0.01026 |
| Implied Shares Outstanding | 76,027,668 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-06-17 |
| Language | en-US |
| Last Fiscal Year End | 1,735,603,200 |
| Long Business Summary | Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan. |
| Long Name | Jyong Biotech Ltd. |
| Market | us_market |
| Market Cap | 172,582,800 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_1853012762 |
| Most Recent Quarter | 1,751,241,600 |
| Net Income To Common | -2,945,000 |
| Next Fiscal Year End | 1,767,139,200 |
| Non Diluted Market Cap | 171,479,770 |
| Open | 2.29 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 886 2 2732 5205 |
| Previous Close | 2.31 |
| Price Hint | 4 |
| Price To Book | -7.252396 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.617 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.03999996 |
| Regular Market Change Percent | -1.6949137 |
| Regular Market Day High | 2.4299 |
| Regular Market Day Low | 2.27 |
| Regular Market Day Range | 2.27 - 2.4299 |
| Regular Market Open | 2.29 |
| Regular Market Previous Close | 2.31 |
| Regular Market Price | 2.27 |
| Regular Market Time | 1,776,784,108 |
| Regular Market Volume | 42,258 |
| Return On Assets | -0.05444 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 74,233,667 |
| Shares Percent Shares Out | 0.0032 |
| Shares Short | 234,254 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 373,692 |
| Short Name | Jyong Biotech Ltd. |
| Short Percent Of Float | 0.0057 |
| Short Ratio | 1.12 |
| Source Interval | 15 |
| Symbol | MENS |
| Total Cash | 17,007,000 |
| Total Cash Per Share | 0.237 |
| Total Debt | 35,194,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 23.638725 |
| Two Hundred Day Average Change | -21.368725 |
| Two Hundred Day Average Change Percent | -0.90397114 |
| Type Disp | Equity |
| Volume | 42,258 |
| Website | https://jyongbio.com |
| Zip | 221 |